Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1059)
Protagonist Therapeutics, Inc (PTGX)
Giraudo Bryan — Director
Shares
6,000
Price
$100.00
Total Value
$600.00K
Shares Held After
0
% of Holdings
100.0%
Sionna Therapeutics, Inc. (SION)
ORBIMED ADVISORS LLC — Director
Shares
59,767
Price
$44.58
Total Value
$2.66M
Shares Held After
2,856,461
% of Holdings
2.0%
Sionna Therapeutics, Inc. (SION)
Thompson Peter A. — Director
Shares
59,767
Price
$44.58
Total Value
$2.66M
Shares Held After
2,856,461
% of Holdings
2.0%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
950
Price
$68.35
Total Value
$64.93K
Shares Held After
4,358,447
% of Holdings
0.0%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
5,076
Price
$67.35
Total Value
$341.85K
Shares Held After
4,359,397
% of Holdings
0.1%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
13,974
Price
$66.65
Total Value
$931.37K
Shares Held After
4,364,473
% of Holdings
0.3%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
950
Price
$68.35
Total Value
$64.93K
Shares Held After
555,686
% of Holdings
0.2%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
5,077
Price
$67.35
Total Value
$341.91K
Shares Held After
556,636
% of Holdings
0.9%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
13,973
Price
$66.65
Total Value
$931.31K
Shares Held After
561,713
% of Holdings
2.4%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Soteropoulos Paula — Director
Shares
599
Price
$85.47
Total Value
$51.20K
Shares Held After
0
% of Holdings
100.0%
Rapport Therapeutics, Inc. (RAPP)
Third Rock Ventures V, L.P. — 10% Owner
Shares
5,018
Price
$40.31
Total Value
$202.26K
Shares Held After
6,432,715
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
520
Price
$571.66
Total Value
$297.27K
Shares Held After
40,513
% of Holdings
1.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
495
Price
$570.22
Total Value
$282.26K
Shares Held After
41,033
% of Holdings
1.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
106
Price
$569.61
Total Value
$60.38K
Shares Held After
41,528
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
360
Price
$568.16
Total Value
$204.54K
Shares Held After
41,634
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
319
Price
$567.21
Total Value
$180.94K
Shares Held After
41,994
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
705
Price
$565.99
Total Value
$399.02K
Shares Held After
42,313
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,983
Price
$564.77
Total Value
$1.12M
Shares Held After
43,018
% of Holdings
4.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,864
Price
$564.00
Total Value
$1.05M
Shares Held After
45,001
% of Holdings
4.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,022
Price
$563.06
Total Value
$1.14M
Shares Held After
46,865
% of Holdings
4.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,126
Price
$562.08
Total Value
$632.91K
Shares Held After
48,887
% of Holdings
2.3%
MBX Biosciences, Inc. (MBX)
Azoulay Salomon — Chief Medical Officer
Shares
15,003
Price
$38.30
Total Value
$574.61K
Shares Held After
14,769
% of Holdings
50.4%
MBX Biosciences, Inc. (MBX)
Azoulay Salomon — Chief Medical Officer
Shares
55,000
Price
$38.38
Total Value
$2.11M
Shares Held After
14,769
% of Holdings
78.8%
UroGen Pharma Ltd. (URGN)
Schoenberg Mark — Chief Medical Officer
Shares
10,000
Price
$30.00
Total Value
$300.00K
Shares Held After
134,985
% of Holdings
6.9%
Spyre Therapeutics, Inc. (SYRE)
HENDERSON MICHAEL THOMAS — Director
Shares
19,269
Price
$75.35
Total Value
$1.45M
Shares Held After
88,606
% of Holdings
17.9%
Spyre Therapeutics, Inc. (SYRE)
HENDERSON MICHAEL THOMAS — Director
Shares
24,814
Price
$74.76
Total Value
$1.86M
Shares Held After
107,875
% of Holdings
18.7%
Spyre Therapeutics, Inc. (SYRE)
HENDERSON MICHAEL THOMAS — Director
Shares
33,513
Price
$73.72
Total Value
$2.47M
Shares Held After
132,689
% of Holdings
20.2%
Spyre Therapeutics, Inc. (SYRE)
HENDERSON MICHAEL THOMAS — Director
Shares
2,404
Price
$72.57
Total Value
$174.46K
Shares Held After
166,202
% of Holdings
1.4%
Showing 501–550 of 1059 transactions (page 11 of 22)